Biontech Se ADR (BNTX)

$105.03 -1.02 (-0.96%)
Market Cap 25.40B
Revenue (ttm) 2.98B
Net Income (ttm) -719.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.18%
Debt to Equity Ratio 0.01
Volume 351,864
Avg Vol 927,588
Day's Range N/A - N/A
Shares Out 240.40M
Stochastic %K 67%
Beta 1.45
Analysts Strong Sell
Price Target $135.84

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
SuperGreenToday
SuperGreenToday Oct. 28 at 7:21 PM
$BNTX Share Price: $105.46 Contract Selected: Mar 20, 2026 $105 Calls Buy Zone: $9.94 – $12.29 Target Zone: $18.75 – $22.92 Potential Upside: 78% ROI Time to Expiration: 142 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
taxplanr
taxplanr Oct. 28 at 6:01 PM
$PFE $BNTX $MRNA
1 · Reply
shashg
shashg Oct. 28 at 3:56 PM
$ALNY $IONS $VRTX $BNTX $CRSP
0 · Reply
SBAlpha
SBAlpha Oct. 28 at 3:03 PM
$ALNY $IONS $VRTX $BNTX $CRSP
0 · Reply
AlphaByAI
AlphaByAI Oct. 28 at 2:43 PM
$ALNY $IONS $VRTX $BNTX $CRSP A deep dive into 5 Longevity stocks. https://newsletter.ai-wk.com/p/aging-longevity-watchlist
0 · Reply
taxplanr
taxplanr Oct. 28 at 2:12 AM
Swedish study confirms C19 bioweapons change human DNA $PFE $BNTX $MRNA https://www.instagram.com/reel/DQRr4Ckibmd/?igsh=MWMweWVqM3JjaWh6YQ==
0 · Reply
JaredSotken
JaredSotken Oct. 27 at 11:55 PM
$BNTX 😏
1 · Reply
webstersenior6
webstersenior6 Oct. 27 at 11:50 PM
$BNTX $LH Buy on pullback https://stocktwits.com/jaredevans1/message/633847474
0 · Reply
taxplanr
taxplanr Oct. 27 at 2:02 PM
real BREAKING NEWS: Canada's most famous COVID-19 Vaccine pushing doctor, Dr.Nili Kaplan-Myrth, has just been diagnosed with Uterine Cancer. Nili ran "Jabapalooza" Clinics in Ottawa $BNTX $MRNA $PFE https://makisw.substack.com/p/breaking-news-canadas-most-famous?utm_source=post-email-title&publication_id=1385328&post_id=177220761&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
2 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 27 at 10:01 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BNTX Current Share Price: $105.66 Contracts: $BNTX January 15, 2027 $110 Calls Scale in: $18.59- $22.72 Scale out: $28.92-$37.18 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Latest News on BNTX
BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 28, 2025, 7:45 AM EDT - 9 hours ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

Oct 27, 2025, 7:45 AM EDT - 1 day ago

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Oct 22, 2025, 6:45 AM EDT - 6 days ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 10 days ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

MRNA

BioNTech SE, InstaDeep Ltd - Special Call

Oct 1, 2025, 6:52 PM EDT - 26 days ago

BioNTech SE, InstaDeep Ltd - Special Call

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 23, 2025, 6:45 AM EDT - 5 weeks ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 5 weeks ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

Sep 12, 2025, 1:37 PM EDT - 6 weeks ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

Sep 8, 2025, 2:01 PM EDT - 7 weeks ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BMY

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

Sep 8, 2025, 11:05 AM EDT - 7 weeks ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 11:00 AM EDT - 7 weeks ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Pfizer, partner BioNTech say updated COVID shot shows better immune response

Sep 8, 2025, 7:02 AM EDT - 7 weeks ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

PFE

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Sep 8, 2025, 6:45 AM EDT - 7 weeks ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

PFE

BioNTech, Duality score initial trial win with breast cancer precision drug

Sep 5, 2025, 5:13 AM EDT - 7 weeks ago

BioNTech, Duality score initial trial win with breast cancer precision drug

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Aug 27, 2025, 12:50 PM EDT - 2 months ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

PFE

CureVac settles patent dispute litigation with Pfizer and BioNTech

Aug 7, 2025, 9:00 PM EDT - 2 months ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 5, 2025, 1:36 PM EDT - 3 months ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:56 PM EDT - 3 months ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 10:32 AM EDT - 3 months ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 7:01 AM EDT - 3 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:52 AM EDT - 3 months ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 4, 2025, 6:45 AM EDT - 3 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Aug 1, 2025, 4:51 PM EDT - 3 months ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 3 months ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 3 months ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Aug 1, 2025, 5:59 AM EDT - 3 months ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Pandemic darlings Moderna, BioNTech are now on two different paths

Jul 31, 2025, 7:00 AM EDT - 3 months ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 3 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 3 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

PFE

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

Jul 23, 2025, 4:11 AM EDT - 3 months ago

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

PFE

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

Jul 21, 2025, 6:45 AM EDT - 3 months ago

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Jul 17, 2025, 8:30 AM EDT - 3 months ago

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Jul 10, 2025, 7:18 AM EDT - 3 months ago

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

MRNA PFE

5 Stocks To Ride The German Market Rally

Jun 16, 2025, 3:06 PM EDT - 4 months ago

5 Stocks To Ride The German Market Rally

FMS SAP

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal

Jun 12, 2025, 11:07 AM EDT - 4 months ago

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal

CVAC

BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.

Jun 12, 2025, 7:11 AM EDT - 4 months ago

BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.

CVAC

BioNTech to acquire CureVac in $1.25 billion all-stock deal

Jun 12, 2025, 7:03 AM EDT - 4 months ago

BioNTech to acquire CureVac in $1.25 billion all-stock deal

CVAC

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Jun 12, 2025, 6:45 AM EDT - 4 months ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

Jun 10, 2025, 11:50 AM EDT - 5 months ago

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

MRK MRNA PFE

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 5 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

MRNA NVAX PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 5 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

MRNA NVAX PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 5 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

MRNA NVAX PFE SNY

Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment

Jun 6, 2025, 7:00 AM EDT - 5 months ago

Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment

BMY

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Jun 3, 2025, 3:34 PM EDT - 5 months ago

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

AZN GILD PFE AMGN BMY MRK

Bristol Myers CEO explains why he's spending billions on BioNTech deal

Jun 2, 2025, 3:50 PM EDT - 5 months ago

Bristol Myers CEO explains why he's spending billions on BioNTech deal

BMY

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

Jun 2, 2025, 2:51 PM EDT - 5 months ago

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

BMY BPMC MRK SNY

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

Jun 2, 2025, 12:22 PM EDT - 5 months ago

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

BMY

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

Jun 2, 2025, 11:08 AM EDT - 5 months ago

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

BMY

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

Jun 2, 2025, 8:46 AM EDT - 5 months ago

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

BMY

SuperGreenToday
SuperGreenToday Oct. 28 at 7:21 PM
$BNTX Share Price: $105.46 Contract Selected: Mar 20, 2026 $105 Calls Buy Zone: $9.94 – $12.29 Target Zone: $18.75 – $22.92 Potential Upside: 78% ROI Time to Expiration: 142 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
taxplanr
taxplanr Oct. 28 at 6:01 PM
$PFE $BNTX $MRNA
1 · Reply
shashg
shashg Oct. 28 at 3:56 PM
$ALNY $IONS $VRTX $BNTX $CRSP
0 · Reply
SBAlpha
SBAlpha Oct. 28 at 3:03 PM
$ALNY $IONS $VRTX $BNTX $CRSP
0 · Reply
AlphaByAI
AlphaByAI Oct. 28 at 2:43 PM
$ALNY $IONS $VRTX $BNTX $CRSP A deep dive into 5 Longevity stocks. https://newsletter.ai-wk.com/p/aging-longevity-watchlist
0 · Reply
taxplanr
taxplanr Oct. 28 at 2:12 AM
Swedish study confirms C19 bioweapons change human DNA $PFE $BNTX $MRNA https://www.instagram.com/reel/DQRr4Ckibmd/?igsh=MWMweWVqM3JjaWh6YQ==
0 · Reply
JaredSotken
JaredSotken Oct. 27 at 11:55 PM
$BNTX 😏
1 · Reply
webstersenior6
webstersenior6 Oct. 27 at 11:50 PM
$BNTX $LH Buy on pullback https://stocktwits.com/jaredevans1/message/633847474
0 · Reply
taxplanr
taxplanr Oct. 27 at 2:02 PM
real BREAKING NEWS: Canada's most famous COVID-19 Vaccine pushing doctor, Dr.Nili Kaplan-Myrth, has just been diagnosed with Uterine Cancer. Nili ran "Jabapalooza" Clinics in Ottawa $BNTX $MRNA $PFE https://makisw.substack.com/p/breaking-news-canadas-most-famous?utm_source=post-email-title&publication_id=1385328&post_id=177220761&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
2 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 27 at 10:01 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BNTX Current Share Price: $105.66 Contracts: $BNTX January 15, 2027 $110 Calls Scale in: $18.59- $22.72 Scale out: $28.92-$37.18 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MrPfizer
MrPfizer Oct. 27 at 2:50 AM
$BNTX can this be $400 by 2027 ?
0 · Reply
stewardhughes
stewardhughes Oct. 25 at 9:25 PM
$BNTX $LH Fund rebalancing https://stocktwits.com/colindequincey/message/633715093
0 · Reply
Pillemann1
Pillemann1 Oct. 25 at 1:01 PM
$BNTX why 130? This is just a 50% share…👍
0 · Reply
ShortTrapSignal
ShortTrapSignal Oct. 24 at 9:58 PM
$NVAX 33.6% short float | 11 days to cover | 41% dark pool shorts 👀 Sanofi confirms Nuvaxovid sales surge 📈 The only non-mRNA vaccine tech with big pharma backing. Undervalued? Or next squeeze candidate? 🚀 “When 45M shares are short with 11DTC, the spark doesn’t need to be big to ignite a move 🔥” #NVAX #ShortSqueeze #HighShortInterest #BiotechStocks #ProteinBasedVaccine #Sanofi #VaccineStocks #Pharma #XBI #IBB #ARKG #NASDAQ #Pfizer #Moderna #Biontech #MomentumStocks #ShortCovering $MRNA, $PFE, $BNTX
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 24 at 9:47 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BNTX Current Share Price: $103.40 Contracts: $BNTX January 15, 2027 $105 Calls Scale in: $17.96- $21.95 Scale out: $27.93-$35.91 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
JaredSotken
JaredSotken Oct. 24 at 8:05 PM
$CVAC Why are you even tagging me on this ticker that I am not in? Trying to justify your stupidity on $BNTX ? 😅 @taxplanr
0 · Reply
JaredSotken
JaredSotken Oct. 24 at 7:57 PM
$BNTX STFU 🤣
0 · Reply
Andrewfritzen01
Andrewfritzen01 Oct. 24 at 6:57 PM
$BNTX $CVAC $PFE so… using all debt to purchase. Not a great sign of the times.
1 · Reply
taxplanr
taxplanr Oct. 24 at 2:31 PM
Using the bodies own mitochondria to combat cancers chronic illnesses and autoimmune diseases is what emf device companies like $ECOR can do Not failed malignantRNA platforms with toxic chemo does $BNTX $MRNA $BMY
0 · Reply
JaredSotken
JaredSotken Oct. 24 at 1:48 PM
$BNTX 130 🎯
1 · Reply
JaredSotken
JaredSotken Oct. 24 at 1:43 PM
$BNTX Did it look like the price cared? 🤭
1 · Reply
JaredSotken
JaredSotken Oct. 24 at 10:54 AM
$BNTX Accumulating
1 · Reply